|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010054,
umls-concept:C0014442,
umls-concept:C0023779,
umls-concept:C0023820,
umls-concept:C0032105,
umls-concept:C0082608,
umls-concept:C0087111,
umls-concept:C0103306,
umls-concept:C0441587,
umls-concept:C0871261,
umls-concept:C1442161,
umls-concept:C1704632,
umls-concept:C1704675,
umls-concept:C1706817,
umls-concept:C1882417,
umls-concept:C2603343,
umls-concept:C2911692
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2000-1-24
|
|
pubmed:abstractText |
Our objectives were to determine whether angiotensin-1 converting enzyme (ACE) insertion/deletion (I/D) polymorphism was associated with the severity of coronary artery disease (CAD) and its progression/regression in response to fluvastatin therapy in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) population.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
89-95
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10636265-Adult,
pubmed-meshheading:10636265-Aged,
pubmed-meshheading:10636265-Cholesterol, LDL,
pubmed-meshheading:10636265-Chromosome Aberrations,
pubmed-meshheading:10636265-Chromosome Deletion,
pubmed-meshheading:10636265-Coronary Artery Disease,
pubmed-meshheading:10636265-Disease Progression,
pubmed-meshheading:10636265-Fatty Acids, Monounsaturated,
pubmed-meshheading:10636265-Female,
pubmed-meshheading:10636265-Genetic Predisposition to Disease,
pubmed-meshheading:10636265-Genotype,
pubmed-meshheading:10636265-Humans,
pubmed-meshheading:10636265-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:10636265-Indoles,
pubmed-meshheading:10636265-Lipids,
pubmed-meshheading:10636265-Male,
pubmed-meshheading:10636265-Middle Aged,
pubmed-meshheading:10636265-Myocardial Infarction,
pubmed-meshheading:10636265-Peptidyl-Dipeptidase A,
pubmed-meshheading:10636265-Polymorphism, Genetic,
pubmed-meshheading:10636265-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.
|
|
pubmed:affiliation |
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. amarian@bcm.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
